Squarepoint’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-1,112,137
| Closed | -$13.7M | – | 5628 |
|
|
2024
Q4 | $13.7M | Buy |
1,112,137
+1,064,258
| +2,223% | +$12.2M | 0.01% | 966 |
|
|
2024
Q3 | $545K | Sell |
47,879
-3,054
| -6% | -$30.7K | ﹤0.01% | 3027 |
|
|
2024
Q2 | $364K | Sell |
50,933
-341,119
| -87% | -$2.61M | ﹤0.01% | 3302 |
|
|
2024
Q1 | $2.63M | Buy |
392,052
+107,635
| +38% | +$740K | ﹤0.01% | 1916 |
|
|
2023
Q4 | $1.85M | Buy |
284,417
+260,832
| +1,106% | +$1.68M | ﹤0.01% | 2053 |
|
|
2023
Q3 | $223K | Buy |
+23,585
| New | +$284K | ﹤0.01% | 3348 |
|
|
2023
Q2 | – | Sell |
-31,172
| Closed | -$585K | – | 4112 |
|
|
2023
Q1 | $585K | Buy |
+31,172
| New | +$512K | ﹤0.01% | 2216 |
|
|
2022
Q4 | – | Sell |
-10,686
| Closed | -$204K | – | 3692 |
|
|
2022
Q3 | $204K | Sell |
10,686
-30,377
| -74% | -$553K | ﹤0.01% | 2686 |
|
|
2022
Q2 | $627K | Buy |
+41,063
| New | +$607K | ﹤0.01% | 1889 |
|
|
2022
Q1 | – | Sell |
-18,604
| Closed | -$543K | – | 3666 |
|
|
2021
Q4 | $543K | Sell |
18,604
-3,595
| -16% | -$103K | ﹤0.01% | 2083 |
|
|
2021
Q3 | $479K | Sell |
22,199
-75,895
| -77% | -$1.83M | ﹤0.01% | 1991 |
|
|
2021
Q2 | $2.52M | Buy |
98,094
+46,801
| +91% | +$1,000K | 0.01% | 1063 |
|
|
2021
Q1 | $935K | Buy |
51,293
+20,021
| +64% | +$333K | 0.01% | 1562 |
|
|
2020
Q4 | $361K | Buy |
+31,272
| New | +$286K | ﹤0.01% | 2067 |
|
|
2020
Q3 | – | Sell |
-75,611
| Closed | -$496K | – | 2911 |
|
|
2020
Q2 | $496K | Buy |
+75,611
| New | +$422K | 0.01% | 1320 |
|
|
2017
Q3 | – | Sell |
-20,871
| Closed | -$89K | – | 1936 |
|
|
2017
Q2 | $89K | Buy |
20,871
+14,814
| +245% | +$60.6K | ﹤0.01% | 1419 |
|
|
2017
Q1 | $28K | Sell |
6,057
-60,957
| -91% | -$204K | ﹤0.01% | 1468 |
|
|
2016
Q4 | $145K | Buy |
+67,014
| New | +$157K | 0.01% | 1550 |
|
|
2016
Q3 | – | Sell |
-16,486
| Closed | -$42K | – | 1308 |
|
|
2016
Q2 | $42K | Buy |
+16,486
| New | +$46K | ﹤0.01% | 1037 |
|
|
2016
Q1 | – | Sell |
-1,586
| Closed | -$13K | – | 1493 |
|
|
2015
Q4 | $13K | Buy |
+1,586
| New | +$12.8K | ﹤0.01% | 1213 |
|
Other funds holding CDMO
Squarepoint's CDMO Position: Q1 2025 in Review
Squarepoint sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q1 2025, closing a stake of 1,112,137 shares — an estimated $13.7M sold.
Squarepoint first reported a position in CDMO in Q4 2015 and held it in 20 quarters. The position peaked at $13.7M in Q4 2024. 2 funds tracked by Wall St. Rank hold CDMO as of Q1 2025.
- Squarepoint reported no remaining Avid Bioservices, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
- Squarepoint sold 1,112,137 Avid Bioservices, Inc. Common Stock shares in Q1 2025, an estimated $13.7M.
- Squarepoint first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2015 and held it in 20 quarters.
- Squarepoint's Avid Bioservices, Inc. Common Stock position peaked at $13.7M in Q4 2024.
- 2 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q1 2025.
Based on Squarepoint's 13F filing for Q1 2025, filed 15 May 2025.